Literature DB >> 16340213

Population genetics of wild-type CAG repeats in the Machado-Joseph disease gene in Portugal.

M Lima1, M C Costa, R Montiel, A Ferro, C Santos, C Silva, C Bettencourt, A Sousa, J Sequeiros, P Coutinho, P Maciel.   

Abstract

OBJECTIVE: To gain insights on the molecular mechanisms of mutation that led to the emergence of expanded alleles in the MJD gene, by studying the behavior of wild-type alleles and testing the association of its distribution with the representation of the disease.
METHODS: The number of CAG motifs in the MJD gene was determined in a representative sample of 1000 unrelated individuals. Associations between the repeat size and the epidemiological representation of MJD were tested.
RESULTS: The allelic profile of the total sample was in the normal range (13-41 repeats), with mode (CAG)23. No intermediate alleles were present. Allelic size distribution showed a negative skew. The correlation between the epidemiological representation of MJD in each district and the frequency of small, medium and large normal alleles was not significant. Further correlations performed grouping the districts also failed to produce significant results.
CONCLUSIONS: The absence of association between the size of the repeats and the representation of MJD demonstrates that prevalence is not an indirect reflection of the frequency of large normal alleles. Globally the results obtained are in accordance with a model that postulates the occurrence of a few mutations on the basis of most of the MJD cases worldwide. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16340213     DOI: 10.1159/000090035

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  13 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

Review 2.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

3.  Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.

Authors:  Maria do Carmo Costa; Naila S Ashraf; Svetlana Fischer; Yemen Yang; Emily Schapka; Gnanada Joshi; Thomas J McQuade; Rahil M Dharia; Mark Dulchavsky; Michelle Ouyang; David Cook; Duxin Sun; Martha J Larsen; Jason E Gestwicki; Sokol V Todi; Magdalena I Ivanova; Henry L Paulson
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

4.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

5.  Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal).

Authors:  Conceição Bettencourt; Raquel Nunes Fialho; Cristina Santos; Rafael Montiel; Jácome Bruges-Armas; Patrícia Maciel; Manuela Lima
Journal:  J Hum Genet       Date:  2008-02-20       Impact factor: 3.172

6.  High frequency of Machado-Joseph disease identified in southeastern Chinese kindreds with spinocerebellar ataxia.

Authors:  Shi-Rui Gan; Sheng-Sheng Shi; Jian-Jun Wu; Ning Wang; Gui-Xian Zhao; Sheng-Tong Weng; Shen-Xing Murong; Chuan-Zhen Lu; Zhi-Ying Wu
Journal:  BMC Med Genet       Date:  2010-03-25       Impact factor: 2.103

7.  Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Katiuska Luna-Cancalon; Svetlana Fischer; Naila S Ashraf; Michelle Ouyang; Rahil M Dharia; Lucas Martin-Fishman; Yemen Yang; Vikram G Shakkottai; Beverly L Davidson; Edgardo Rodríguez-Lebrón; Henry L Paulson
Journal:  Mol Ther       Date:  2013-06-14       Impact factor: 11.454

8.  Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease.

Authors:  Naila S Ashraf; Sara Duarte-Silva; Emily D Shaw; Patrícia Maciel; Henry L Paulson; Andreia Teixeira-Castro; Maria do Carmo Costa
Journal:  Mol Neurobiol       Date:  2018-09-04       Impact factor: 5.590

9.  Population genetics and new insight into range of CAG repeats of spinocerebellar ataxia type 3 in the Han Chinese population.

Authors:  Shi-Rui Gan; Wang Ni; Yi Dong; Ning Wang; Zhi-Ying Wu
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

10.  Epidemiological, clinical, and molecular characterization of Cuban families with spinocerebellar ataxia type 3/Machado-Joseph disease.

Authors:  Yanetza González-Zaldívar; Yaimeé Vázquez-Mojena; José M Laffita-Mesa; Luis E Almaguer-Mederos; Roberto Rodríguez-Labrada; Gilberto Sánchez-Cruz; Raúl Aguilera-Rodríguez; Tania Cruz-Mariño; Nalia Canales-Ochoa; Patrick MacLeod; Luis Velázquez-Pérez
Journal:  Cerebellum Ataxias       Date:  2015-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.